Effect of Food on the Pharmacokinetics of LY2157299 Monohydrate in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 03 Dec 2013
Price : $35 *
At a glance
- Drugs Galunisertib (Primary)
- Indications Glioblastoma; Glioma; Liver cancer; Pancreatic cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 01 Dec 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Nov 2013 Planned End Date changed from 1 Dec 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 27 Oct 2013 New trial record